Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Universal Health Services Inc. (UHS:NYSE), powered by AI.
Universal Health Services Inc. is currently trading at $146.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Universal Health Services Inc. on Alpha Lenz.
Universal Health Services Inc.'s P/E ratio is 6.3.
“Universal Health Services Inc. trades at a P/E of 6.3 (undervalued) with strong ROE of 21.4%.”
Ask for details →Universal Health Services Inc. is a prominent operator in the healthcare management and administration sector. Its primary function is the provision of hospital and healthcare services, owning and operating a diversified range of healthcare facilities across the United States. These include acute care hospitals, behavioral health facilities, and ambulatory centers, serving a wide array of patients' needs. Universal Health Services Inc. is notable for its comprehensive healthcare delivery, impacting multiple areas of the healthcare industry, including emergency care, mental health, and outpatient surgeries. The company plays a crucial role in the healthcare market by addressing the rising demand for accessible and quality medical services, as well as providing specialized healthcare solutions. Through its extensive network of facilities, Universal Health Services Inc. meets the healthcare requirements of communities while contributing significantly to healthcare infrastructure. Its operations are integral to the effective functioning of local and regional healthcare systems, helping to ensure that essential medical services are continuously available to those in need.
“Universal Health Services Inc. trades at a P/E of 6.3 (undervalued) with strong ROE of 21.4%.”
Ask for details →Universal Health Services Inc. (ticker: UHS) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 99,300 employees. Market cap is $9.3B.
The current price is $146.9 with a P/E ratio of 6.27x and P/B of 1.28x.
ROE is 21.36% and operating margin is 11.48%. Annual revenue is $17.4B.